Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

CRBP holding history

Corbus Pharmaceuticals Holdings, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRBP overviewAll 13F holders of CRBPFull Q2 2026 holdings

Shares (Q2 2026)
48,797
Value
$457.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CRBP by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202648,797$457.7K<0.1%+10,159+26.3%AddedHolders
Q1 202638,638$362.8K<0.1%−12,571−24.5%ReducedHolders
Q4 202551,209$416.8K<0.1%−8,287−13.9%ReducedHolders
Q3 202559,496$752.6K<0.1%−32,347−35.2%ReducedHolders
Q2 202591,843$633.7K<0.1%+999+1.1%AddedHolders
Q1 202590,844$482.4K<0.1%+1,467+1.6%AddedHolders
Q4 202489,377$1.05M<0.1%+65,162+269.1%AddedHolders
Q3 202424,215$499.6K<0.1%+2,566+11.9%AddedHolders
Q2 202421,649$979.6K<0.1%+6,184+40.0%AddedHolders
Q1 202415,465$606.8K<0.1%+15,144+4,717.8%AddedHolders
Q4 2023321$1.94K<0.1%−861−72.8%ReducedHolders
Q3 20231,182$7.97K<0.1%+879+290.1%AddedHolders
Q2 2023303$2.38K<0.1%−4,541−93.7%ReducedHolders
Q1 20234,844$35.2K<0.1%+3,845+385.1%AddedConverted for a 1-for-30 splitHolders
Q4 202229,956$3.30K<0.1%−12,548−29.5%ReducedHolders
Q3 202242,504$7.00K<0.1%+40,553+2,078.6%AddedHolders
Q2 20221,951$00.0%−19,428−90.9%ReducedHolders
Q1 202221,379$11.0K<0.1%−17,201−44.6%ReducedHolders
Q4 202138,580$24.0K<0.1%+27,868+260.2%AddedHolders
Q3 202110,712$12.0K<0.1%−7,113−39.9%ReducedHolders
Q2 202117,825$33.0K<0.1%−1,843−9.4%ReducedHolders
Q1 202119,668$39.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.